The Primary Prevention: What’s causing the rise in Type 1 diabetes—and can it be stopped?
Name
dinneen-jdinneen-sm-21w-2022-thesis.pdf
Description
Thesis PDF
Size
177.78 KB
Format
Adobe PDF
Checksum (MD5)
16b57407e79aedb906ef1df5550e7a4b
Author(s)
Dinneen, James
Advisor(s)
Tingley, Kim
Date Issued
September 2022
Publisher
Massachusetts Institute of Technology
Abstract
Decades of research have failed to identify the environmental factors behind rising rates of Type 1 diabetes. However, the search has made Type 1 diabetes one of the best studied autoimmune diseases, with a network of clinics and laboratories dedicated to understanding the interplay of genetic and environmental factors behind the disease. This has enabled clinicians to begin testing treatments to prevent diabetes in high-risk patients at the “primary” phase when all there is to go on is genetic risk. This thesis discusses the search for environmental determinants of diabetes in the context of a primary prevention clinical trial underway at the Institute for Diabetes Research in Munich, Germany. The trial and others underway represent a possible answer for the millions of people at high genetic risk for developing Type 1 diabetes, and other associated autoimmune conditions like celiac disease and allergies. They also offer an early view into the promise and pitfalls of precision medicine.
MIT Department
Massachusetts Institute of Technology. Program in Comparative Media Studies/Writing
Massachusetts Institute of Technology. Graduate Program in Science Writing
Terms of Use
In Copyright - Educational Use Permitted
Copyright retained by author(s)
Persistent DSpace Link
